DRIVE PARTNERS WITH QVELLA CORPORATION TO DEVELOP AN MRNA- BASED ASSAY TO RAPIDLY IDENTIFY INFECTION AND SEPTIC PATIENTS IN UNDER 1 HOUR February 21, 2019 The […]
Qvella Raises US$20M in Series B Financing to Fund Clinical Trials, On-going Research, Team Expansion, and Manufacturing Buildup New strategic investor bioMérieux will explore collaborative opportunities […]
Please wait while you are redirected to the right page...